SEC Filings

10-Q
ENVISION HEALTHCARE CORP filed this Form 10-Q on 08/08/2017
Entire Document
 
Item 1. Financial Statements - (continued)

As of June 30, 2017, the Company had total unrecognized compensation cost of approximately $58.3 million related to non-vested awards, which the Company expects to recognize through 2020 and over a weighted average period of 1.0 years. For the three and six months ended June 30, 2017 and 2016, there were 529,637 and no options that were anti-dilutive, respectively.

d. Earnings per Share
 
Basic net earnings (loss) attributable to Envision Healthcare Corporation common stockholders, per common share, excludes dilution and is computed by dividing net earnings (loss) attributable to Envision Healthcare Corporation common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net earnings (loss) attributable to Envision Healthcare Corporation common stockholders, per common share is computed by dividing net earnings (loss) attributable to Envision Healthcare Corporation common stockholders by the weighted-average number of common shares outstanding during the period plus any potential dilutive common share equivalents, including shares issuable (i) upon the vesting of restricted stock awards, restricted stock units and performance stock units as determined under the treasury stock method and (ii) upon conversion of the Company's mandatory convertible preferred stock as determined under the if-converted method. For purposes of calculating diluted earnings (loss) per share, preferred stock dividends have been subtracted from both net earnings (loss) from continuing operations attributable to Envision Healthcare Corporation and net earnings (loss) attributable to Envision Healthcare Corporation common stockholders in periods in which utilizing the if-converted method would be anti-dilutive.

The following is a reconciliation of the numerator and denominators of basic and diluted earnings (loss) per share (dollars in millions; per share amounts in thousands):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
Earnings
 
Shares
 
Per Share
 
Earnings
 
Shares
 
Per Share
 
(Numerator)
 
(Denominator)
 
Amount
 
(Numerator)
 
(Denominator)
 
Amount
2017:
 

 
 

 
 

 
 

 
 
 
 

Net earnings from continuing operations attributable to Envision Healthcare Corporation common stockholders (basic)
$
50.2

 
116,852

 
$
0.43

 
$
80.9

 
116,708

 
$
0.69

Effect of dilutive securities, options and non-vested shares

 
2,729

 
 

 

 
2,820

 
 

Net earnings from continuing operations attributable to Envision Healthcare Corporation common stockholders (diluted)
$
50.2

 
119,581

 
$
0.42

 
$
80.9

 
119,528

 
$
0.68

 
 
 
 
 
 
 
 
 
 
 
 
2016:
 
 
 
 
 

 
 
 
 

 
 

Net earnings from continuing operations attributable to Envision Healthcare Corporation common stockholders (basic)
$
43.8

 
53,739

 
$
0.82

 
$
72.4

 
53,702

 
$
1.35

Preferred stock dividends
2.2

 

 
 
 
4.5

 

 
 
Effect of dilutive securities, options and non-vested shares

 
3,588

 
 
 

 
3,527

 
 
Net earnings attributable to Envision Healthcare Corporation common stockholders (diluted)
$
46.0

 
57,327

 
$
0.80

 
$
76.9

 
57,229

 
$
1.34


26